Navigation Links
RadQual, LLC Announces a New Industry Leading Dose Calibrator Reference Standard
Date:2/14/2011

WEARE, N.H., Feb. 14, 2011 /PRNewswire/ -- RadQual, LLC, a premier developer of innovative quality control products for nuclear medicine, SPECT, and positron emission tomography (PET) imaging, is pleased to announce the only dose calibrator standard directly traceable to the National Institute of Standards and Technology (NIST) for accurate measurement of gallium-68 and fluorine-18 is now available up to a 1 millicurie (37 MBq) strength.  Fluorine-18 is an important isotope in the radiopharmaceutical industry, and is primarily synthesized into fluorodeoxyglucose (FDG) for use in positron emission tomography (PET) scans.  This new RadQual dose calibrator standard will help provide PET scan manufactures and end users a true dose calibrator standard to ensure compliance with many state and federal regulatory standards for accurate calibration of patient dose measurement.

Historically most facilities have been using cesium-137 or sodium-22 standards for Ga-68 and F-18 calibration.  RadQual has conducted a thorough study, in conjunction with NIST, which has determined that the old standards produced a measurement error as high as 17% when trying to measure F-18 doses.

Keith Allberg, RadQual's Director of Manufacturing and Regulatory Affairs said, "We believe our new dose calibrator reference standard will make a significant difference to the industry.  Our continuing study of facilities using or producing Ga-68 and F-18 worldwide indicates those facilities are incorrectly measuring the amount of radionuclide by as much as 19% and 17% respectively.  In addition, the information reported for F-18 has shown as great as a 27% difference between two different competitors' brands of dose calibrators and as much as a 9% difference within the same competitors brand and model.  The well-established practice of using either cesium-137 or sodium-22 for daily calibration of PET radionuclide dose measurement for patient injection is simply inaccurate and could be significantly improved by using the new RadQual calibration standard."In other Company news, RadQual LLC recently formed a new joint venture business on a 50-50 ownership basis with International Isotopes, Inc. (OTC Bulletin Board: INIS), www.intisoid.com, and has acquired the assets of Technology Imaging Services Inc. (TIS).  TIS had been a major distributor of products and services for nuclear medicine, nuclear cardiology, and PET imaging.  In 2009 Technology Imaging had gross revenues of about $6 million.  The new joint venture will be called T I Services LLC.

About RadQual, LLC

RadQual, LLC, is the premier developer of innovative quality control products for the nuclear medicine and PET imaging communities. Founded in 2001, RadQual is the only remaining American owned provider of SPECT imaging radioactive sealed sources for routine quality control. Our quality products are manufactured in Idaho Falls, ID, and distributed worldwide through a select group of dealers and nuclear pharmacies. RadQual is dedicated to the production of quality control devices for medical imaging.For more information contact:Peter OuimetteRadQual, LLCWeare, NH508-833-1005   Or visit our web site at: www.radqual.com/
'/>"/>

SOURCE RadQual, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Genesis Biopharma Announces Management and Board Changes
2. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
3. Orexigen® Therapeutics Announces Corporate Realignment
4. Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders
5. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
6. Stem Cell Assurance Announces Engagement of Marcum LLP as its Independent Auditors
7. Pancreatic Cancer Action Network Announces New Initiative to Double the Survival Rate for Pancreatic Cancer Patients by 2020
8. Thermal Gradient Announces Breakthrough in Fast PCR Device Technology
9. Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
10. Fuisz Pharma Announces Patented Communication of Analyte Information Between Microchip Containing Smart Tablet and a Body Fluid Analyzer
11. MetaMorphix, Inc. Announces Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... -- Market Research Future published a half-cooked research report on Global Cancer ... a CAGR of 12% during the period 2016 to 2022. ... ... division without any control. These abnormal cells have the ability to ... can spread to other parts of the body through the blood ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... Noom Inc. , the leader ... offer fully Spanish behavior change programs that address ... prevention and healthy weight management programs  have ... interventions among Hispanic Americans who are at increased ... database, program-specific curriculum content and program features are ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of the North American Spine Society (NASS)1 demonstrate high fusion rates at ... cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The implantable ...
Breaking Biology Technology:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)...   Avanade is helping Williams Martini Racing, ... history, exploit biometric data in order to critically analyse ... competitive edge against their rivals after their impressive, record-breaking ... has worked with Williams during the 2016 season to ... rate, breathing rate, temperature and peak acceleration) for key ...
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
Breaking Biology News(10 mins):